Toxoplasma gondii (Tg) is an obligate intracellular category B priority pathogen that serves as a model system for other priority B protozoa including Cryptosporidium parvum and Cyclospora cayetanensis. Tg is the causative agent of toxoplasmosis, a known health hazard in immunocompromised individuals including transplant recipients. Our overall goal is to determine mechanisms used by Tg to protect itself against cell autonomous immunity. Mechanisms Tg has evolved to protect itself within its host cell likely underlie its ability to use phagocytes to disseminate to the brain and CNS to survive to establish chronic infection and to persist within cysts long term to enable reactivation of disease. In previous studies we used an unbiased approach to let Tg identify for us the defenses it has evolved to protect itself from cell autonomous immunity. Unexpectedly, we isolated a panel of independently- derived Tg mutants that all share a pronounced inability to withstand nitrosative stress (RNS) characterized by fragmentation of the parasites'sole mitochondrion suggestive of RNS-induced parasite autophagy resulting in parasite stasis or degradation. The mutants are also impaired for their ability to establish/maintain chronic infection in vivo. The goal of this R3 proposal is to use the mutants we have isolated to identify Tg genes important for conferring resistance to RNS as well as for in vivo infection. We have identified the genomic site of plasmid insertion for four of the mutants. These four genes that appear to be unique to Tg will be deleted in wild type (WT) parasites to validate their role in parasite resistance to RNS. Whole genome mutational profiling has only recently become a productive method to identify single nucleotide polymorphisms (SNPs) and insertions/deletions in chemical and insertional Tg mutant. We will use this new innovation to identify the plasmid insertion site in seven other mutants where the primary gene disruption remains unknown. The proposal fulfills the goal of the R03 grant mechanism as the identification of the parasite genes important for resistance to RNS is a secondary analysis of the mutants identified in our previous forward genetic screen and as such is a defined extension of the original study.

Public Health Relevance

Proposed studies are likely to identify vulnerabilities in Toxoplasma that increase its susceptibility to reactive nitrogen species. Ultimately these studies may allow the design of reactive nitrogen species-based therapeutics against the cyst stage to eliminate chronic infection and prevent disease reactivation.

Agency
National Institute of Health (NIH)
Institute
National Institute of Allergy and Infectious Diseases (NIAID)
Type
Small Research Grants (R03)
Project #
1R03AI107431-01A1
Application #
8701670
Study Section
Pathogenic Eukaryotes Study Section (PTHE)
Program Officer
Rogers, Martin J
Project Start
2014-04-07
Project End
2016-03-31
Budget Start
2014-04-07
Budget End
2015-03-31
Support Year
1
Fiscal Year
2014
Total Cost
$80,500
Indirect Cost
$30,500
Name
New York Medical College
Department
Microbiology/Immun/Virology
Type
Schools of Medicine
DUNS #
041907486
City
Valhalla
State
NY
Country
United States
Zip Code
10595